Newtyn Management, LLC Sensei Biotherapeutics, Inc. Transaction History

Newtyn Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.73 - $1.17 $468,508 - $750,897	-641,793 Reduced 40.83%	930,230 $976,000
Q4 2023 Feb 14, 2024	SELL	$0.53 - $0.82 $120,827 - $186,941	-227,977 Reduced 12.67%	1,572,023 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$0.75 - $1.32 $20,430 - $35,956	-27,240 Reduced 1.49%	1,800,000 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.81 $326,404 - $518,239	286,320 Added 18.58%	1,827,240 $2.08 Million
Q1 2023 May 15, 2023	BUY	$1.31 - $1.7 $504,820 - $655,110	385,359 Added 33.35%	1,540,920 $2.31 Million
Q4 2022 Feb 14, 2023	BUY	$1.33 - $1.74 $984,946 - $1.29 Million	740,561 Added 178.45%	1,155,561 $1.72 Million
Q2 2022 Aug 15, 2022	BUY	$1.49 - $2.3 $618,350 - $954,499	415,000 New	415,000 $942,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $15.1M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Newtyn Management, LLC with notifications on news.